P-Nitrophenol

Identification

Generic Name
P-Nitrophenol
DrugBank Accession Number
DB04417
Background

Not Available

Type
Small Molecule
Groups
Experimental
Structure
Weight
Average: 139.1088
Monoisotopic: 139.026943031
Chemical Formula
C6H5NO3
Synonyms
Not Available
External IDs
  • NSC-1317

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
TargetActionsOrganism
USulfotransferase 1A1Not AvailableHumans
UAlpha-amylase 2BNot AvailableHumans
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Categories

Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as nitrophenols. These are compounds containing a nitrophenol moiety, which consists of a benzene ring bearing both a hydroxyl group and a nitro group on two different ring carbon atoms.
Kingdom
Organic compounds
Super Class
Benzenoids
Class
Phenols
Sub Class
Nitrophenols
Direct Parent
Nitrophenols
Alternative Parents
Nitrobenzenes / Nitroaromatic compounds / 1-hydroxy-2-unsubstituted benzenoids / Propargyl-type 1,3-dipolar organic compounds / Organic oxoazanium compounds / Organopnictogen compounds / Organooxygen compounds / Organonitrogen compounds / Organic oxides / Hydrocarbon derivatives
Substituents
1-hydroxy-2-unsubstituted benzenoid / Allyl-type 1,3-dipolar organic compound / Aromatic homomonocyclic compound / C-nitro compound / Hydrocarbon derivative / Monocyclic benzene moiety / Nitroaromatic compound / Nitrobenzene / Nitrophenol / Organic 1,3-dipolar compound
Molecular Framework
Aromatic homomonocyclic compounds
External Descriptors
mononitrophenol (CHEBI:16836)
Affected organisms
Not Available

Chemical Identifiers

UNII
Y92ZL45L4R
CAS number
100-02-7
InChI Key
BTJIUGUIPKRLHP-UHFFFAOYSA-N
InChI
InChI=1S/C6H5NO3/c8-6-3-1-5(2-4-6)7(9)10/h1-4,8H
IUPAC Name
4-nitrophenol
SMILES
OC1=CC=C(C=C1)[N+]([O-])=O

References

General References
Not Available
Human Metabolome Database
HMDB0001232
KEGG Compound
C00870
PubChem Compound
980
PubChem Substance
46507119
ChemSpider
955
ChEBI
16836
ChEMBL
CHEMBL14130
ZINC
ZINC000034828682
Therapeutic Targets Database
DNC000371
PDBe Ligand
NPO
Wikipedia
4-Nitrophenol
PDB Entries
1ls6 / 1vah / 1yek / 1z44 / 2d20 / 2i10 / 2wgz / 2zvp / 2zyv / 2zyw
show 59 more

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
PropertyValueSource
melting point (°C)113.8 °CPhysProp
boiling point (°C)279 °CPhysProp
water solubility1.16E+004 mg/L (at 20 °C)SCHWARZENBACH,RP ET AL (1988)
logP1.91HANSCH,C ET AL. (1995)
logS-0.74ADME Research, USCD
pKa7.15 (at 25 °C)SERJEANT,EP & DEMPSEY,B (1979)
Predicted Properties
PropertyValueSource
Water Solubility3.6 mg/mLALOGPS
logP1.93ALOGPS
logP1.61Chemaxon
logS-1.6ALOGPS
pKa (Strongest Acidic)7.07Chemaxon
pKa (Strongest Basic)-7.1Chemaxon
Physiological Charge-1Chemaxon
Hydrogen Acceptor Count3Chemaxon
Hydrogen Donor Count1Chemaxon
Polar Surface Area63.37 Å2Chemaxon
Rotatable Bond Count1Chemaxon
Refractivity34.36 m3·mol-1Chemaxon
Polarizability12.22 Å3Chemaxon
Number of Rings1Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterNoChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
PropertyValueProbability
Human Intestinal Absorption+0.9864
Blood Brain Barrier+0.7201
Caco-2 permeable+0.5667
P-glycoprotein substrateNon-substrate0.8778
P-glycoprotein inhibitor INon-inhibitor0.8776
P-glycoprotein inhibitor IINon-inhibitor0.9865
Renal organic cation transporterNon-inhibitor0.8919
CYP450 2C9 substrateNon-substrate0.7621
CYP450 2D6 substrateNon-substrate0.8076
CYP450 3A4 substrateNon-substrate0.5179
CYP450 1A2 substrateInhibitor0.5893
CYP450 2C9 inhibitorNon-inhibitor0.8259
CYP450 2D6 inhibitorNon-inhibitor0.952
CYP450 2C19 inhibitorNon-inhibitor0.8826
CYP450 3A4 inhibitorNon-inhibitor0.8723
CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.812
Ames testNon AMES toxic0.7376
CarcinogenicityNon-carcinogens0.5316
BiodegradationNot ready biodegradable0.7261
Rat acute toxicity2.7067 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.6671
hERG inhibition (predictor II)Non-inhibitor0.9204
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSsplash10-000i-7900000000-d4915e2347113b56d32c
GC-MS Spectrum - EI-BGC-MSsplash10-00kr-9200000000-6a367c2627bf30cad163
GC-MS Spectrum - EI-BGC-MSsplash10-00or-9500000000-a23a22fc322241325904
GC-MS Spectrum - EI-BGC-MSsplash10-000i-9400000000-670d24ff2b2b121a7ab8
GC-MS Spectrum - EI-BGC-MSsplash10-000i-9400000000-b5aea5436a88b29179e9
GC-MS Spectrum - EI-BGC-MSsplash10-05n0-9300000000-f284a324180bf4d7ffc2
GC-MS Spectrum - EI-BGC-MSsplash10-0006-2009127011-85632179856636169d28
GC-MS Spectrum - GC-EI-TOFGC-MSsplash10-0f6t-1900000000-70af7d7902cd35a26f29
Mass Spectrum (Electron Ionization)MSsplash10-00kr-9300000000-d76f14df8da868057d44
MS/MS Spectrum - Quattro_QQQ 10V, N/ALC-MS/MSsplash10-00dl-0900000000-653240f82298b3880e70
MS/MS Spectrum - Quattro_QQQ 25V, N/ALC-MS/MSsplash10-014l-9100000000-1dd6a69ee33aeb4207a3
MS/MS Spectrum - Quattro_QQQ 40V, N/ALC-MS/MSsplash10-014r-9000000000-397a0913b382e58ae418
MS/MS Spectrum - EI-B (HITACHI RMU-7M) , PositiveLC-MS/MSsplash10-00kr-9200000000-039471e02c3307757a0c
MS/MS Spectrum - EI-B (HITACHI RMU-6M) , PositiveLC-MS/MSsplash10-00or-9500000000-a23a22fc322241325904
MS/MS Spectrum - EI-B (Unknown) , PositiveLC-MS/MSsplash10-000i-9400000000-12717928037244536b6b
MS/MS Spectrum - EI-B (HITACHI M-60) , PositiveLC-MS/MSsplash10-000i-9400000000-f133ed564f0a12bd3871
MS/MS Spectrum - EI-B (HITACHI M-80) , PositiveLC-MS/MSsplash10-05n0-9300000000-d39a8dbf21962717a2ee
LC-MS/MS Spectrum - LC-ESI-QTOF (UPLC Q-Tof Premier, Waters) , PositiveLC-MS/MSsplash10-0002-9200000000-bff0a2a3c15629cc6ec2
LC-MS/MS Spectrum - LC-ESI-QTOF (UPLC Q-Tof Premier, Waters) , NegativeLC-MS/MSsplash10-052r-0900000000-1279a141e229fec8dbd4
LC-MS/MS Spectrum - LC-ESI-QTOF , negativeLC-MS/MSsplash10-052r-0900000000-1279a141e229fec8dbd4
LC-MS/MS Spectrum - LC-ESI-QTOF , positiveLC-MS/MSsplash10-0002-9200000000-bff0a2a3c15629cc6ec2
1H NMR Spectrum1D NMRNot Applicable
1H NMR Spectrum1D NMRNot Applicable
13C NMR Spectrum1D NMRNot Applicable
1H NMR Spectrum1D NMRNot Applicable
13C NMR Spectrum1D NMRNot Applicable
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
[1H,13C] 2D NMR Spectrum2D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-126.8195585
predicted
DarkChem Lite v0.1.0
[M-H]-126.8264585
predicted
DarkChem Lite v0.1.0
[M-H]-126.8405585
predicted
DarkChem Lite v0.1.0
[M-H]-127.247375
predicted
DeepCCS 1.0 (2019)
[M+H]+128.1235585
predicted
DarkChem Lite v0.1.0
[M+H]+127.9529585
predicted
DarkChem Lite v0.1.0
[M+H]+127.8852585
predicted
DarkChem Lite v0.1.0
[M+H]+130.38191
predicted
DeepCCS 1.0 (2019)
[M+Na]+126.9565585
predicted
DarkChem Lite v0.1.0
[M+Na]+126.9407585
predicted
DarkChem Lite v0.1.0
[M+Na]+127.2541585
predicted
DarkChem Lite v0.1.0
[M+Na]+139.25574
predicted
DeepCCS 1.0 (2019)

Targets

Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock new
insights and accelerate drug research.
Learn more
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
Learn more
Kind
Protein
Organism
Humans
Pharmacological action
Unknown
General Function
Sulfotransferase activity
Specific Function
Sulfotransferase that utilizes 3'-phospho-5'-adenylyl sulfate (PAPS) as sulfonate donor to catalyze the sulfate conjugation of catecholamines, phenolic drugs and neurotransmitters. Has also estroge...
Gene Name
SULT1A1
Uniprot ID
P50225
Uniprot Name
Sulfotransferase 1A1
Molecular Weight
34165.13 Da
References
  1. Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [Article]
  2. Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [Article]
Kind
Protein
Organism
Humans
Pharmacological action
Unknown
General Function
Not Available
Specific Function
Alpha-amylase activity
Gene Name
AMY2B
Uniprot ID
P19961
Uniprot Name
Alpha-amylase 2B
Molecular Weight
57709.49 Da
References
  1. Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [Article]
  2. Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [Article]
  3. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article]

Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52